Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Sintilimab and Stereotactic Body Radiotherapy in Advanced Metastatic Hepatocellular Carcinoma

NCT04547452 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT04547452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04547452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Sintilimab and Stereotactic Body Radiotherapy in Advanced Metastatic Hepatocellular Carcinoma
Lead sponsor
West China Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
July 1, 2020
Completion date
July 1, 2023
Enrollment
84 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunotherapy, sbrt, stage iv hcc